Literature DB >> 15004177

Increased dendritic cell numbers impair protective immunity to intracellular bacteria despite augmenting antigen-specific CD8+ T lymphocyte responses.

Robert C Alaniz1, Sharsti Sandall, Elaine K Thomas, Christopher B Wilson.   

Abstract

Dendritic cells (DCs) reside in tissues, where they function as sentinels, providing an essential link between innate and adaptive immunity. Increasing the numbers of DCs in vivo augments T cell responses, and can cause dramatic CTL-dependent tumor regression. To determine whether greater DC numbers promoted T cell-mediated protection in the context of host defense against intracellular bacteria, we treated mice with Flt3 ligand (Flt3-L) to increase DCs in vivo and challenged them with Listeria monocytogenes. Unexpectedly, after primary challenge with Listeria, the overall control of Listeria infection was impaired in Flt3-L-treated mice, which had greater bacterial burden and mortality than controls. Similar results were obtained when DC numbers were increased by treatment with polyethylene glycol-conjugated GM-CSF rather than Flt3-L and in mice infected with Mycobacterium tuberculosis. Impaired protection was not due to dysfunctional T cell responses, as Flt3-L-treated mice had a greater frequency and absolute number of Ag-specific CD8+ T cells, which produced IFN-gamma, exhibited cytolytic activity, and transferred protection. The increased Listeria burden in Flt3-L-treated mice was preferentially associated with DCs, which were unable to kill Listeria and more resistant to CTL lysis compared with macrophages in vitro. Although we cannot exclude the possibility that other potential effects, in addition to increased numbers of DCs, are shared by Flt3-L and polyethylene glycol-conjugated GM-CSF and contributed to the increase in susceptibility observed in treated mice, these results support the notion that DC numbers must be properly controlled within physiological limits to optimize host defense to intracellular bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004177     DOI: 10.4049/jimmunol.172.6.3725

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Immunoregulation of dendritic cells.

Authors:  Mark A Wallet; Pradip Sen; Roland Tisch
Journal:  Clin Med Res       Date:  2005-08

2.  IL-10-Dependent Crosstalk between Murine Marginal Zone B Cells, Macrophages, and CD8α+ Dendritic Cells Promotes Listeria monocytogenes Infection.

Authors:  Dong Liu; Xiangyun Yin; Sam J Olyha; Manuela Sales L Nascimento; Pei Chen; Theresa White; Uthaman Gowthaman; Tingting Zhang; Jake A Gertie; Biyan Zhang; Lan Xu; Marina Yurieva; Lesley Devine; Adam Williams; Stephanie C Eisenbarth
Journal:  Immunity       Date:  2019-06-20       Impact factor: 31.745

Review 3.  Dendritic cells: arbiters of immunity and immunological tolerance.

Authors:  Kanako L Lewis; Boris Reizis
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

4.  Coregulatory interactions among CD8α dendritic cells, the latency-associated transcript, and programmed death 1 contribute to higher levels of herpes simplex virus 1 latency.

Authors:  Kevin R Mott; Sariah J Allen; Mandana Zandian; Homayon Ghiasi
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

5.  Salmonella pathogenicity island 1 differentially modulates bacterial entry to dendritic and non-phagocytic cells.

Authors:  Susan M Bueno; Aniela Wozniak; Eduardo D Leiva; Sebastián A Riquelme; Leandro J Carreño; Wolf-Dietrich Hardt; Claudia A Riedel; Alexis M Kalergis
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

6.  Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling.

Authors:  Taheri Sathaliyawala; William E O'Gorman; Melanie Greter; Milena Bogunovic; Vjollca Konjufca; Z Esther Hou; Garry P Nolan; Mark J Miller; Miriam Merad; Boris Reizis
Journal:  Immunity       Date:  2010-10-07       Impact factor: 31.745

7.  Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis.

Authors:  Jacek Szeliga; D Sundarsingh Daniel; Ching-Hui Yang; Zvjezdana Sever-Chroneos; Chinnaswamy Jagannath; Zissis C Chroneos
Journal:  Tuberculosis (Edinb)       Date:  2007-10-24       Impact factor: 3.131

8.  FMS-like tyrosine kinase 3 ligand treatment of mice aggravates acute lung injury in response to Streptococcus pneumoniae: role of pneumolysin.

Authors:  Christina Brumshagen; Regina Maus; Andrea Bischof; Bianca Ueberberg; Jennifer Bohling; John J Osterholzer; Abiodun D Ogunniyi; James C Paton; Tobias Welte; Ulrich A Maus
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441

9.  Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.

Authors:  James A Triccas; Elena Shklovskaya; Joanne Spratt; Anthony A Ryan; Umaimainthan Palendira; Barbara Fazekas de St Groth; Warwick J Britton
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

10.  Cytokine treatment of macrophage suppression of T cell activation.

Authors:  Daniel Silberman; Amanda Bucknum; Megan Kozlowski; Robin Matlack; James Riggs
Journal:  Immunobiology       Date:  2009-02-26       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.